Pharmaceuticals

Manufacturers, Distributors, Pharmacies Opioid Epidemic RICO Case

A very large multi-district litigation (MDL) case on opioids is currently working its way through the court system, with multiple complaints, long lists of defendants, and around 3,500 documents currently on file. The complaints bring suit against a group of manufacturers, marketers, distributors, national pharmacies, and pharmacy benefit managers, for creating or contributing to the  Read more

Sanguenol ED Supplement Alleged to Be Unapproved Drug Class Action

If a company claims that its supplements are for “the prevention, cure, mitigation, and therapeutic treatment of disease,” then they are considered to be drugs and must be regulated and approved by the Food and Drug Administration (FDA). The complaint for this class action alleges that North American Nutraceuticals, LLC has been selling “illegal, unapproved  Read more

Jazz Pharmaceuticals Anticompetitive Agreements on Xyrem Class Action

In recent years, we’ve seen a number of antitrust cases where a pharmaceutical company with a lucrative drug is accused of conspiring with generics companies to keep generic versions of that drug off the market. This class action alleges that Jazz Pharmaceuticals, related Jazz companies, and a long list of other drug companies conspired to  Read more

AstraZeneca Seroquel XR Generic Delay Antitrust Class Action

A number of antitrust class actions in recent years have centered on covert agreements between a company with a popular and lucrative drug and one or more other companies who may wish to put out a generic version. In this antitrust class action, the complaint claims that AstraZeneca companies entered into agreements with Handa Pharmaceuticals,  Read more

CVS Makes Opioid Buyers Get Overdose Drug California Class Action

Can a pharmacy force you to purchase a drug you don’t want in order to allow you to purchase one that you have a prescription for? The complaint alleges that CVS Pharmacy, Inc. and CVS Health Corporation are forcing customers who want a prescription for an opioid-containing drug filled to also purchase prescribed medication Naloxone  Read more

Suboxone Antitrust Settlement

Reckitt Benckiser Group plc is settling a Federal Trade Commission (FTC) antitrust action against it for $60 million. Suboxone is used to treat opioid addiction. The complaint alleged that the company tried to retain its market and thwart the makers of generics in order to keep its monopoly. According to the complaint, it tried to  Read more

Opioid Makers, Distributors Sued for Problems with Newborns Class Action

The plaintiffs in this case are two babies, Baby AM and Baby RH, who were born dependent on opioids. The complaint says, “The first days of Baby Plaintiffs’ lives were spent in excruciating pain as doctors weaned the infants from opioid addiction.” This class action brings suit against a long list of pharmaceutical makers, and  Read more

Thalomid and Revlimid Antitrust Settlement

Celgene is settling, for the second time, an antitrust class action alleging that it took action to prevent or delay the entry of cheaper generics to the market. The complaint alleged that consumers and third-party payors were forced to pay higher prices for than they would have had generics been available. Celgene was able to  Read more

Drug Companies and Baby Addiction Florida Class Action

The plaintiffs in this class action are babies born dependent on opioids, and their mothers. The complaint offers a very long list of defendant companies, including distributors, manufacturers, and marketers. (See the complaint linked below for the full list of companies.) It says, “Baby Plaintiffs and their mothers are victims of the opioid crisis that  Read more

Pfizer, Ranbaxy Lipitor Generic Anticompetitive Agreement Class Action

With the high prices of US drugs, a popular medicine can be an enormous moneymaker for a pharmaceutical company. But the patents that give those companies exclusivity have a limited term, after which generics or bioequivalents can come on the market, driving prices downwards. The complaint for this antitrust class action alleges that a number  Read more